Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1728158 | 0.88 | ALDH1A1 (0.33) | GSK3AGSK3BALDH1A1MAPTKMT2A | |
| SCHEMBL12660974 | 0.78 | ALDH1A1 (0.47) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL23310487 | 0.73 | ALDH1A1 (0.47) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL11847806 | 0.72 | GSK3A (0.54) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL16004440 | 0.69 | GSK3A (0.50) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL20225070 | 0.69 | ALDH1A1 (0.39) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL12895942 | 0.68 | ALOX15 (0.47) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL13259494 | 0.68 | ALDH1A1 (0.44) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL10807279 | 0.67 | ALDH1A1 (0.73) | GSK3AGSK3BALDH1A1MAPTPKM | |
| SCHEMBL20808155 | 0.66 | ALDH1A1 (0.49) | ALDH1A1MAPTPKMKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9221837-B2 | Process for preparing dithiine-tetracarboximides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-29 | — | — | US | claimed |
| US-8450360-B2 | Process for preparing dithiine-tetracarboximides | BAYER CROPSCIENCE AG (DE) | 2013-05-28 | — | — | US | claimed |
| US-20110269973-A1 | Process for Preparing Dithiine-tetracarboximides | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | US | claimed |
| EP-2558473-B1 | METHOD FOR PRODUCING DITHIIN TETRACARBOXIMIDES | BAYER IP GMBH (DE) | 2016-09-07 | — | — | EP | disclosed |
| EP-2828268-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | Bayer CropScience AG (DE) | 2015-01-28 | — | — | EP | disclosed |
| US-20140296536-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-10-02 | — | — | US | disclosed |
| EP-2611814-B1 | METHOD FOR PRODUCING DITHIIN-TETRACARBOXIMIDES | BAYER IP GMBH (DE) | 2014-09-24 | — | — | EP | disclosed |
| US-20140256956-A1 | METHOD FOR PRODUCING DITHINE TETRACARBOXIMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-09-11 | — | — | US | disclosed |
| EP-2766371-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | Bayer Intellectual Property GmbH (DE) | 2014-08-20 | — | — | EP | disclosed |
| EP-2766372-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | Bayer Intellectual Property GmbH (DE) | 2014-08-20 | — | — | EP | disclosed |
| WO-2013139736-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | BAYER CROPSCIENCE AG (DE) | 2013-09-26 | — | — | WO | disclosed |
| EP-2641908-A1 | Method for producing dithiin tetracarboximides | Bayer CropScience AG (DE) | 2013-09-25 | — | — | EP | disclosed |
| EP-2611814-A1 | METHOD FOR PRODUCING DITHIIN-TETRACARBOXIMIDES | Bayer Intellectual Property GmbH (DE) | 2013-07-10 | — | — | EP | disclosed |
| US-8450360-B2 | Process for preparing dithiine-tetracarboximides | BAYER CROPSCIENCE AG (DE) | 2013-05-28 | — | — | US | disclosed |
| WO-2013053783-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013053784-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-04-18 | — | — | WO | disclosed |
| EP-2558473-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | Bayer CropScience AG (DE) | 2013-02-20 | — | — | EP | disclosed |
| WO-2012028588-A1 | METHOD FOR PRODUCING DITHIIN-TETRACARBOXIMIDES | BAYER CROPSCIENCE AG (DE) | 2012-03-08 | — | — | WO | disclosed |
| US-20110269973-A1 | Process for Preparing Dithiine-tetracarboximides | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | US | disclosed |
| WO-2011128263-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | BAYER CROPSCIENCE AG (DE) | 2011-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256956-A1 | METHOD FOR PRODUCING DITHINE TETRACARBOXIMIDES | TST, TXNDC5, TXN | GSK3A 4670/4885GSK3B 4610/4885ALDH1A1 2104/4885 |
| US-20110269973-A1 | Process for Preparing Dithiine-tetracarboximides | TMT1A, TST, DTYMK | GSK3A 4823/4885GSK3B 4755/4885ALDH1A1 3929/4885 |
| US-20140296536-A1 | METHOD FOR PRODUCING DITHIINE TETRACARBOXIMIDES | TST, TXNDC5, TMT1A | GSK3A 4574/4885GSK3B 4511/4885ALDH1A1 2833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.